Antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates in Murcia, Spain;Sensibilidad a antimicrobianos de aislamientos clínicos de Pseudomonas aeruginosa en Murcia

Revista Espanola de Quimioterapia

Volumn 16, Issue 4, 2003, Pages 444-449

  Guerrero, C ^a,b   Cesteros, R ^a   Miranda, A ^a   Menasalvas, A ^a   Blazquez R ^a   Segovia, M ^a  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

Antimicrobial susceptibility; Pseudomonas aeruginosa; Resistance

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; HOSPITAL PATIENT; INTENSIVE CARE UNIT; NONHUMAN; OUTPATIENT DEPARTMENT; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; SPAIN; URINE;

ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; SPAIN;

EID: 0842321945     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rello, J., Torres, A. Microbial causes of ventilator-associated pneumonia. Semin respir Infect 1996; 11: 24-31.
2. Maschmeyer, G., Braveny, I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 2000; 19: 915-925.
3. Arruda, E.A., Marinho, I.S., Boulos, M. y cols. Nosocomial infections caused by multirresistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 1999; 20: 620-623.
4. Chen, H.Y., Yuan, M., Ibrahim-Elmagboul I.B., Livermore, D.M. National survey of susceptibility to antimicrobials among clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 1995; 35: 521-534.
5. Henwood, C. J., Livermore, D. M., James, D., Warner, M., and the Pseudomonas Study Group. Antimicrobial susceptibility of Pseudomonas aeruginosa: Results of a survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test. J Antimicrob Chemother 2001; 47: 789-799.
6. Bonfiglio, G. S., Garciotto, V., Russo, G. y cols. Antibiotic resistance in Pseudomonas aeruginosa: An Italian survey. J Antimicrob Chemother 1998; 41: 307-310.
7. Fluit, A.C., Verhoef, J., Schmitz, F. J., and the European SENTRY Participants. Antimicrobial resistance in Europe isolates of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 2000; 19: 370-374.
8. Bouza, E., García-Garrote, F., Cercenado, E., Marín, M., Díaz, M.S. Pseudomonas aeruginosa: A survey of resistance in 136 hospitals in Spain. Antimicrob Agents Chemotherapy 1999; 43: 981-982.
9. Fluit, A. C., Schimitz, F. J., Verhoef, J., and the European SENTRY Participants Group. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract injections ocurring in european patients. Eur J Clin Infect Dis 2001; 20: 188-191.
10. Cercenado, E.Y., García Garrote, F. Mecanismos de resistencia en Pseudomonas aeruginosa. Rev Clin Esp 1998; 198: 10-16.
11. Gobernado, M. Antibióticos activos frente a Pseudomonas aeruginosa y su uso clínico. Rev Clin Esp 1998; 198: 51-61.
12. Nicolas, T., Matthew, H.S., Yehuda, C. Imipenem resistant Pseudomonas aeruginosa: Risk factors and antibiotic susceptibility patterns. Clin Infect Dis 1997; 25: 1094-1098.
13. Yehuda, C., Nicolas, T., George, M.E., Matthew, H.S. Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risk associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999; 43: 1379-1382.
14. Schmitz, F.J., Verhoef, J., Fluit, A.C., and the SENTRY Participants Group. Prevalence of aminoglycoside resistance in 20 European University Hospitals participating in the European SENTRY antimicrobial surveillance programme. Eur J Clin Microbiol Infect Dis 1999; 18: 414-421.